Free Trial

Hennion & Walsh Asset Management Inc. Has $1.36 Million Stock Holdings in Indivior PLC (NASDAQ:INDV)

Indivior logo with Medical background

Hennion & Walsh Asset Management Inc. grew its holdings in Indivior PLC (NASDAQ:INDV - Free Report) by 48.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 142,444 shares of the company's stock after purchasing an additional 46,509 shares during the quarter. Hennion & Walsh Asset Management Inc. owned approximately 0.10% of Indivior worth $1,357,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Rathbones Group PLC grew its holdings in shares of Indivior by 11.6% in the 4th quarter. Rathbones Group PLC now owns 14,284 shares of the company's stock valued at $183,000 after buying an additional 1,483 shares during the period. Two Sigma Investments LP grew its stake in Indivior by 2.1% in the fourth quarter. Two Sigma Investments LP now owns 110,880 shares of the company's stock valued at $1,378,000 after acquiring an additional 2,237 shares during the period. Stifel Financial Corp increased its holdings in shares of Indivior by 24.0% in the fourth quarter. Stifel Financial Corp now owns 12,675 shares of the company's stock worth $158,000 after acquiring an additional 2,450 shares in the last quarter. PDT Partners LLC raised its position in shares of Indivior by 4.7% during the fourth quarter. PDT Partners LLC now owns 57,520 shares of the company's stock worth $715,000 after purchasing an additional 2,596 shares during the period. Finally, GF Fund Management CO. LTD. bought a new position in shares of Indivior during the 4th quarter valued at about $36,000. Institutional investors own 60.33% of the company's stock.

Analysts Set New Price Targets

Separately, Piper Sandler reduced their target price on shares of Indivior from $16.00 to $13.00 and set an "overweight" rating for the company in a research note on Thursday, March 6th.

Check Out Our Latest Research Report on INDV

Indivior Stock Up 1.9%

Shares of NASDAQ:INDV traded up $0.26 during midday trading on Tuesday, hitting $13.69. The stock had a trading volume of 1,064,121 shares, compared to its average volume of 1,086,594. The company has a market cap of $1.89 billion, a P/E ratio of -39.11 and a beta of 0.66. Indivior PLC has a 12 month low of $7.33 and a 12 month high of $17.09. The business's 50-day simple moving average is $10.94 and its 200-day simple moving average is $10.89.

Indivior (NASDAQ:INDV - Get Free Report) last announced its quarterly earnings data on Thursday, April 24th. The company reported $0.41 EPS for the quarter, beating analysts' consensus estimates of $0.22 by $0.19. The company had revenue of $266.00 million during the quarter, compared to the consensus estimate of $240.13 million. Indivior had a negative net margin of 3.96% and a negative return on equity of 241.73%. As a group, equities analysts predict that Indivior PLC will post 1.22 earnings per share for the current year.

About Indivior

(Free Report)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.

Further Reading

Institutional Ownership by Quarter for Indivior (NASDAQ:INDV)

Should You Invest $1,000 in Indivior Right Now?

Before you consider Indivior, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Indivior wasn't on the list.

While Indivior currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines